5-Hydroxytryptamine- and U46619-mediated vasoconstriction in bovine pulmonary conventional and supernumerary arteries: Effect of endogenous nitric oxide

Clinical Science

Volumn 98, Issue 1, 2000, Pages 81-89

  Bunton, D ^a   MacDonald, A ^a   Brown, T ^a   Tracey, A ^a   McGrath, J C ^b   Shaw, A M ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

5 Hydroxytryptamine; cGMP; Nitric oxide; Pulmonary supernumerary artery

Indexed keywords

1 (1 METHYL 5 INDOLYL) 3 (3 PYRIDYL)UREA; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CYCLIC GMP; GUANYLATE CYCLASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SEROTONIN; SEROTONIN 2B RECEPTOR;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CATTLE; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; VASOCONSTRICTION;

EID: 0033972598     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0980081     Document Type: Article

References (51)

1. 1 Kanai, Y., Hori, S., Tanaka, T. et al. (1993) Role of 5-hydroxytryptamine in the progression of monocrotaline induced pulmonary hypertension in rats. Cardiovasc. Res. 27, 1619-1623
2. 2 Hervé, P., Launay, J.-M., Scrobohaci, M.-L. et al. (1995) Increased plasma serotonin in primary pulmonary hypertension. Am. J. Med. 99, 249-254
3. 3 Hervé, P., Drouet, L., Dosquet, C. et al. (1990) Primary pulmonary hypertension in a patient with familial storage pool disease: role of serotonin. Am. J. Med. 89, 117-120
4. 4 Kobayashi, Y. and Amenta, F. (1994) Neurotransmitter receptors in the pulmonary circulation with particular emphasis on pulmonary endothelium. J. Auton. Pharmacol. 14, 137-164
5. 5 Gorelova, E., Loesch, A., Bodin, P., Chadwick, L., Hamlyn, P. J. and Burnstock, G. (1996) Localisation of immunoreactive factor VIII, nitric oxide synthase, substance P, endothelin-1 and 5-hydroxytryptamine in human postmortem middle cerebral artery. J. Anat. 188, 97-107
6. 6 Harlon, J., Winn, R. and Weaver, J. (1983) Selective blockade of thromboxane A2 synthesis during experimental E. coli bacteremia in the goat. Chest 83, 75-77
7. 7 Weitzberg, E., Lundberg, J. M. and Rudehill, A. (1995) Inhibitory effects of diclofenac on the endotoxin shock response in relation to endothelin turnover in the pig. Acta Anaesthesiol. Scand. 39, 50-59
8. 8 Dobyns, E. L., Wescott, J. Y., Kennaugh, J. M., Ros, M. N. and Stenmark, K. R. (1994) Eicosanoids decrease with successful extracorporeal membrane oxygenation therapy in neonatal pulmonary hypertension. Am. J. Respir. Crit. Care Med. 149, 873-880
9. 9 Montascelot, G., Lowenstein, E., Ogletree, M. L. et al. (1990) Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep. Circulation 82, 1765-1777
10. 10 Garcia-Szabo, R. R., Johnson, A. and Malik, A. B. (1988) Thromboxane increases pulmonary vascular resistance and transvascular fluid and protein exchange after pulmonary microembolism. Prostaglandins 35, 707-721
11. 11 Barnes, P. J. and Liu, S. F. (1995) Regulation of pulmonary vascular tone. Pharmacol. Rev. 47, 87-131
12. 12 Ignarro, L. J., Byrns, R. E., Buga, G. M. and Wood, K. S. (1987) Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ. Res. 61, 866-879
13. 13 Dinh-Xuan, A. T., Higgenbottam, T. W., Clelland, C. A. et al. (1991) Impairment of endothelium-dependent pulmonary artery relaxation in chronic obstructive rung disease. N. Engl. J. Med. 324, 1539-1547
14. 14 Elliott, F. M. and Reid, L. (1965) Some new facts about the pulmonary artery and its branching pattern. Clin. Radiol. 16, 193-198
15. 15 Hoyer, D. and Martin, G. (1997) 5-HT receptor classification and nomenclature: towards a harmonization with the human genome. Neuropharmacology 36, 419-428
16. 1c receptor antagonist. J. Med. Chem. 36, 1104-1107
17. 2b) in the rat stomach fundus longitudinal muscle. Br. J. Pharmacol. 112, 323-331
18. 18 Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. (1951) J. Biol. Chem. 193, 265-275
19. 1 -like receptor-mediated vasoconstriction in human pulmonary artery. Br. J. Pharmacol. 119, 277-282
20. 20 Le Roux, M. G. J. and Syce, J. A. (1989) The effect of ketanserin on serotonin-induced vascular responses in the isolated perfused rat lung. Eur. J. Pharmacol. 169, 269-273
21. 1-receptor-mediated vasoconstriction in bovine isolated pulmonary arteries: influence of vascular endothelium and tone. Pulm. Pharmacol. 7, 65-72
22. 2. Circ. Res. 72, 1023-1034
23. 23 Brunner, F., Schmidt, K., Nielsen, E. B. and Mayer, B. (1996) Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery. J. Pharmacol. Exp. Ther. 277, 48-53
24. 24 Rees, D. D., Palmer, R. M. J., Schulz, R., Hodson, H. F. and Moncada, S. (1990) Characterisation of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101, 746-752
25. 25 Hyman, A. L., Kadowitz, P. J. and Lippton, H. L. (1989) Methylene blue selectively inhibits pulmonary vasodilator responses in cats. J. Appl. Physiol. 66, 1513-1517
26. 26 Cremona, G., Wood, A. M., Hall, L. W., Bower, E. A. and Higenbottam, T. W. (1994) Effect of inhibitors of nitric oxide release and action on vasculat tone in isolated lungs of pigs, sheeep, dog and man. J. Physiol. (London) 481, 185-195
27. 27 Yamaguchi, T., Rodman, D. M., O'Brien, R. F. and McMurtry, I. F. (1989) Modulation of pulmonary artery contraction by endothelium-derived relaxing factor. Eur. J. Pharmacol. 161, 259-262
28. 28 Kavanagh, B. P., Thompson, J. S. and Pearl, R. G. (1996) Inhibition of endogenous nitric oxide synthase potentiates nitrovasodilators in experimental pulmonary hypertension. Anesthesiology 85, 860-866
29. 29 Brashers, V. L., Peach, M. J. and Rose, Jr., C. E. (1988) Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation. J. Clin. Invest. 82, 1495-1502
30. 30 Crawley, D. E., Liu, S. F., Evans, T. W. and Barnes, P. J. (1990) Inhibitory role of endothelium-derived relaxing factor in rat and human pulmonary arteries. Br. J. Pharmacol. 101, 166-170
31. 31 Bunton, D., MacDonald, A., Brown, T. and Shaw, A. M. (1998) Receptor subtypes for 5-hydroxytryptamine in bovine pulmonary conventional and supernumerary arteries. Br. J. Pharmacol. 125, 100P
32. 32 MacLean, M. R., McCulloch, K. M. and McGrath, J. C. (1993) Influences of the endothelium and hypoxia on α1-and α2-adrenoceptor agonists in the rabbit isolated pulmonary artery. Br. J. Pharmacol. 108, 155-161
33. 33 MacLean, M. R., McCulloch, K. M., Templeton, A. G. B. and Baird, M. (1993) Comparison of rabbit neonate and adult pulmonary arterial responses to 5-hydroxytryptamine. Br. J. Pharmacol. 110, 112P
34. 2 alpha in rat pulmonary artery. Br. J. Pharmacol. 120, 1280-1285
35. 35 Gruetter, C. A., Gruetter, D. Y., Lyon, J. E. et al. (1981) Relationship between cyclic GMP formation and relaxation of coronary arterial smooth muscle by glycerine trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J. Pharmacol. Exp. Ther. 219, 181-186
36. 36 Ignarro, L. J. and Kadowitz, P. J. (1985) The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu. Rev. Pharmacol. Toxicol. 25, 171-191
37. 37 Bolotina, V. M., Najibi, S., Palacino, J. J., Pagano, P. J. and Cohen, M. L. (1994) Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature (London) 368, 850-853
38. + channel of vascular smooth muscle cells. FEBS Lett. 345, 47-49
39. 1c-like receptors mediate endothelium-dependent relaxant response to 5-HT in porcine pulmonary arteries. Naunyn-Schmiedeberg's Arch. Pharmacol. Suppl. 346, R1
40. 1c-like receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 347, 471-477
41. 41 Sumner, M. J. (1991) Characterization of 5-HT receptor mediating endothelium-dependent relaxation in porcine vena cava. Br. J. Pharmacol. 102, 938-942
42. 1c receptors. J. Vasc. Res. 29, 87-94
43. 2B receptors of endothelium-dependent relaxation in rat jugular vein. Br. J. Pharmacol. 114, 400-404
44. 44 Hoyer, D., Clarke, D. E., Fozard, J. R. et al. (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46, 157-203
45. 0-protein-coupled receptors. FASEB J. 9, 745-754
46. 46 Sumner, M. J. and Humphrey, P. P. (1990) Sumatriptan (GR43175) inhibits cyclic-AMP accumulation in dog isolated saphenous vein. Br. J. Pharmacol. 99, 219-220
47. 2-mimetic U46619. Br. J. Pharmacol. 121, 1323-1333
48. 48 de Mello, D and Reid, L. M. (1991) Arteries and veins. In The Lung: Scientific Foundations (Crystal, R. G., West, J. B., Barnes, P. J., Cherniack, N. S. and Weibel, E. R., eds.), pp. 767-778, Raven Press, New York
49. 49 Yaginuma, G., Mohri, H. and Takahashi, T. (1990) Distribution of arterial lesions and collateral pathways in the pulmonary hypertension of congenital heart disease: a computer-aided reconstruction study. Thorax 45, 586-590
50. 50 Fillenz, M. (1970) Innervation of pulmonary and bronchial blood vessels of the dog. J. Anat. 106, 449-461
51. 51 Bunton, D. C., Fisher, A., Shaw., A. M., MacDonald, A., Montgomory, I. and McGrath, J. C. (1996) Musculo-elastic structure at origin of pulmonary supernumerary artery resembles a baffle valve. Br. J. Pharmacol. 119, 323P